Polin Chan

1.9k total citations
48 papers, 986 citations indexed

About

Polin Chan is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Polin Chan has authored 48 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 32 papers in Hepatology and 14 papers in Infectious Diseases. Recurrent topics in Polin Chan's work include Hepatitis C virus research (32 papers), Hepatitis B Virus Studies (30 papers) and HIV, Drug Use, Sexual Risk (14 papers). Polin Chan is often cited by papers focused on Hepatitis C virus research (32 papers), Hepatitis B Virus Studies (30 papers) and HIV, Drug Use, Sexual Risk (14 papers). Polin Chan collaborates with scholars based in China, Philippines and United States. Polin Chan's co-authors include Terence T. Lao, K. F. Tam, Weiming Tang, Fuqiang Cui, Joseph D. Tucker, Zhongdan Chen, Songyuan Tang, Kathrine Meyers, Philippa Easterbrook and Wing Cheong Leung and has published in prestigious journals such as The Lancet, Nature Medicine and PLoS ONE.

In The Last Decade

Polin Chan

47 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Polin Chan China 17 623 436 278 115 91 48 986
Antoine Jaquet France 20 764 1.2× 131 0.3× 352 1.3× 34 0.3× 102 1.1× 61 1.1k
Oluwaseun Falade‐Nwulia United States 20 1.1k 1.8× 1.0k 2.3× 393 1.4× 83 0.7× 73 0.8× 75 1.6k
Bonnie Zimmer United States 17 587 0.9× 47 0.1× 270 1.0× 119 1.0× 126 1.4× 33 1.3k
Lu-Yu Hwang United States 15 1.6k 2.6× 1.2k 2.7× 272 1.0× 152 1.3× 53 0.6× 26 1.9k
Kristen Marks United States 19 676 1.1× 650 1.5× 321 1.2× 20 0.2× 65 0.7× 49 1.1k
Berit Lange Germany 15 318 0.5× 134 0.3× 284 1.0× 49 0.4× 22 0.2× 55 779
Marc A. Pitasi United States 13 777 1.2× 568 1.3× 382 1.4× 17 0.1× 65 0.7× 20 1.1k
Fiona Guerra Canada 10 398 0.6× 70 0.2× 239 0.9× 189 1.6× 17 0.2× 15 822
Mukta Sharma United States 18 395 0.6× 58 0.1× 361 1.3× 13 0.1× 37 0.4× 83 1.0k
Vincenza Règine Italy 16 400 0.6× 89 0.2× 343 1.2× 8 0.1× 148 1.6× 53 628

Countries citing papers authored by Polin Chan

Since Specialization
Citations

This map shows the geographic impact of Polin Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Polin Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Polin Chan more than expected).

Fields of papers citing papers by Polin Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Polin Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Polin Chan. The network helps show where Polin Chan may publish in the future.

Co-authorship network of co-authors of Polin Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Polin Chan. A scholar is included among the top collaborators of Polin Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Polin Chan. Polin Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Arvind Kumar, Polin Chan, Biswanath Dutta, et al.. (2025). Seroprevalence of melioidosis and its associated risk factors –A population-based study in Odisha, Eastern India. Current Research in Microbial Sciences. 8. 100360–100360. 1 indexed citations
2.
Yin, Xueru, Wei Wang, Hui Chen, et al.. (2024). Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China. Nature Medicine. 30(2). 455–462. 17 indexed citations
3.
Wang, Xin, et al.. (2024). Effect of Health Literacy on Antiviral Treatment of Hepatitis B: Instrumental Variable Analysis. JMIR Public Health and Surveillance. 10. e58391–e58391.
4.
Li, Rui, Mingwang Shen, Jason J. Ong, et al.. (2023). Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies. JHEP Reports. 5(10). 100833–100833. 9 indexed citations
5.
Zhang, Lei, Zhuoru Zou, Jason J. Ong, et al.. (2023). Shared-care models are highly effective and cost-effective for managing chronic hepatitis B in China: reinterpreting the primary care and specialty divide. The Lancet Regional Health - Western Pacific. 35. 100737–100737. 6 indexed citations
6.
Sun, He, Shuang Gao, Lan Wang, et al.. (2023). Prevalence and factors associated with hepatitis C among pregnant women in China: a cross-sectional study. Scientific Reports. 13(1). 759–759. 5 indexed citations
7.
8.
Wong, William Chi Wai, Gifty Marley, Jingjing Li, et al.. (2022). A randomized controlled trial enhancing viral hepatitis testing in primary care via digital crowdsourced intervention. npj Digital Medicine. 5(1). 95–95. 6 indexed citations
9.
Marley, Gifty, Wai‐Kay Seto, Polin Chan, et al.. (2022). What facilitates hepatitis B and hepatitis C testing and the role of stigma among primary care patients in China?. Journal of Viral Hepatitis. 29(8). 637–645. 6 indexed citations
10.
Su, Shu, William C.W. Wong, Zhuoru Zou, et al.. (2022). Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation. The Lancet Global Health. 10(2). e278–e287. 63 indexed citations
11.
Song, Yuanyuan, et al.. (2022). Eliminate Hepatitis C as a Public Health Threat: A Narrative Review of Strategies, Gaps, and Opportunities for China. Infectious Diseases and Therapy. 11(4). 1427–1442. 16 indexed citations
12.
Zhang, Peiwen, et al.. (2020). Unblocking Barriers of Access to Hepatitis C Treatment in China: Lessons Learned from Tianjin. Annals of Global Health. 86(1). 36–36. 7 indexed citations
13.
Wong, William C.W., Jingjing Li, Hang Li, et al.. (2020). Crowdsourcing to promote hepatitis C testing and linkage-to-care in China: a randomized controlled trial protocol. BMC Public Health. 20(1). 1048–1048. 6 indexed citations
14.
Fitzpatrick, Thomas, Weiming Tang, Katie R. Mollan, et al.. (2019). A crowdsourced intervention to promote hepatitis B and C testing among men who have sex with men in China: A nationwide online randomized controlled trial. EClinicalMedicine. 16. 64–73. 12 indexed citations
15.
Yuan, Qianli, Fuzhen Wang, Hui Zheng, et al.. (2019). Hepatitis B vaccination coverage among health care workers in China. PLoS ONE. 14(5). e0216598–e0216598. 57 indexed citations
16.
Fitzpatrick, Thomas, Kali Zhou, Yu Cheng, et al.. (2018). A crowdsourced intervention to promote hepatitis B and C testing among men who have sex with men in China: study protocol for a nationwide online randomized controlled trial. BMC Infectious Diseases. 18(1). 489–489. 20 indexed citations
17.
Li, Xi, Polin Chan, Hui Zhuang, et al.. (2018). Prevalence of hepatitis C virus infection among key populations in China: A systematic review. International Journal of Infectious Diseases. 80. 16–27. 20 indexed citations
18.
Tang, Songyuan, Weiming Tang, Kathrine Meyers, et al.. (2016). HIV epidemiology and responses among men who have sex with men and transgender individuals in China: a scoping review. BMC Infectious Diseases. 16(1). 588–588. 92 indexed citations
19.
Leung, Thomas, Wing Cheong Leung, Polin Chan, & Pak‐Cheong Ho. (2002). A comparison of the prevalence of domestic violence between patients seeking termination of pregnancy and other general gynecology patients. International Journal of Gynecology & Obstetrics. 77(1). 47–54. 55 indexed citations
20.
Lao, Terence T., Polin Chan, & K. F. Tam. (2001). Gestational diabetes mellitus in the last trimester – a feature of maternal iron excess?. Diabetic Medicine. 18(3). 218–223. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoine Jaquet Breakdown of academic impact, for papers by Oluwaseun Falade‐Nwulia Breakdown of academic impact, for papers by Bonnie Zimmer Breakdown of academic impact, for papers by Lu-Yu Hwang Breakdown of academic impact, for papers by Kristen Marks Breakdown of academic impact, for papers by Berit Lange Breakdown of academic impact, for papers by Marc A. Pitasi Breakdown of academic impact, for papers by Fiona Guerra Breakdown of academic impact, for papers by Mukta Sharma Breakdown of academic impact, for papers by Vincenza Règine
Rankless by CCL
2026